Call Options

13 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2021

May 17, 2021

SELL
$10.34 - $12.81 $12.8 Million - $15.8 Million
-1,236,700 Reduced 98.88%
14,000 $162,000
Q2 2020

Aug 12, 2020

BUY
$8.12 - $13.12 $5.13 Million - $8.29 Million
631,500 Added 101.99%
1,250,700 $15.4 Million
Q1 2020

May 13, 2020

BUY
$6.69 - $13.45 $4.05 Million - $8.14 Million
605,100 Added 4291.49%
619,200 $5.56 Million
Q4 2019

Feb 14, 2020

BUY
$6.53 - $10.72 $92,073 - $151,152
14,100 New
14,100 $138,000
Q3 2019

Nov 12, 2019

SELL
$6.16 - $9.6 $5.06 Million - $7.88 Million
-820,800 Closed
0 $0
Q2 2019

Aug 12, 2019

SELL
$8.12 - $15.72 $5.68 Million - $11 Million
-699,100 Reduced 46.0%
820,800 $7.58 Million
Q1 2019

May 10, 2019

SELL
$15.58 - $20.01 $6.07 Million - $7.8 Million
-389,600 Reduced 20.4%
1,519,900 $23.8 Million
Q4 2018

Feb 13, 2019

BUY
$14.59 - $23.84 $16.3 Million - $26.7 Million
1,118,100 Added 141.28%
1,909,500 $29.4 Million
Q3 2018

Nov 09, 2018

SELL
$21.06 - $25.65 $6.07 Million - $7.39 Million
-288,100 Reduced 26.69%
791,400 $17 Million
Q2 2018

Aug 08, 2018

SELL
$16.77 - $24.71 $2.19 Million - $3.23 Million
-130,700 Reduced 10.8%
1,079,500 $26.3 Million
Q1 2018

May 09, 2018

BUY
$16.68 - $22.07 $3.41 Million - $4.51 Million
204,500 Added 20.33%
1,210,200 $20.7 Million
Q4 2017

Feb 09, 2018

BUY
$11.23 - $19.1 $10.9 Million - $18.6 Million
974,800 Added 3154.69%
1,005,700 $19.1 Million
Q3 2017

Nov 13, 2017

BUY
$15.41 - $32.17 $476,169 - $994,053
30,900
30,900 $544,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $25.3B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Twin Tree Management, LP Portfolio

Follow Twin Tree Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Twin Tree Management, LP with notifications on news.